SciELO - Scientific Electronic Library Online

vol.27 issue2Treatment and recovery of Wagner 5 diabetic foot with Heberprot-PPostmarketing effectiveness and safety of Heberprot-P for diabetic foot ulcer treatment in Cuba author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Biotecnología Aplicada

On-line version ISSN 1027-2852


MARTINEZ, Reinaldo et al. Non-surgical but efficacious technique for diabetic foot treatment. Biotecnol Apl [online]. 2010, vol.27, n.2, pp.120-123. ISSN 1027-2852.

An increasing portion of diabetic foot ulcer (DFU) patients does not positively responds to common treatments, resulting in partial or complete amputation of the affected limb. DFUs become a health problem, involving several medical specialties, especially Angiology and Endocrinology. There are no products available in the market to treat Wagner grade 3 and 4 ulcers, neither extensive, nor ischemic ulcers. For this purpose, an observational, descriptive, longitudinal and prospective study was carried out to evaluate the therapeutic response of DFU patients who were admitted at the angiology service of the General Teaching Hospital Julio Trigo, from January to June 2010. This report also shows clinical evidences of a representative case, and results achieved in 45 patients who were treated with Heberprot-P. This product becomes a valuable tool in expertise hands for treating patients suffering from that condition. The study was aimed to evaluate the efficacy and safety of the intralesional administration of Heberprot-P in DFUs. It was demonstrated that Heberprot-P improves the quality of life and decrease the amputation rates among these patients.

Keywords : Diabetic foot ulcer; amputation; Heberprot-P.

        · abstract in Spanish     · text in English     · English ( pdf )